alternative to glp 1 for weight loss Understanding GLP-1 pills: A new injections Substitute one high Guide to GLP-1 Alternatives for
Description
The authors are careful to point out that obesity and metabolic syndrome may be a risk factor for mood disorders and they provide an excellent discussion of how trial design and patient selection may have affected these results

Bray et al., 2021

This helps identify competitive pressure points, partnership opportunities, and routes to differentiation

About this article Cite this article Sood, N., Buddhavarapu, V

However, in early November 2023, Eli Lilly's Tirzepatide (marketed under the brand name Mounjaro) was also approved by the FDA for weight-loss therapy and is expected to enter the market soon